If you are using copyrighted QTdrugs information in your capacity as an employee or contractor for a commercial organization, such use is considered commercial by AZCERT's Terms of Use and, as such, requires a license. AZCERT's policy defines non-commercial use as any use by employees of government agencies, academic institutions, not-for-profit entities or self-employed healthcare providers. However, commercial use or reproduction of the QTdrugs list or other copyrighted content from this website is prohibited unless authorized by AZCERT, Inc. The End User Subscription Agreement is available here. Online orders can be placed here and quotations for licensing fees are available by contacting info@azcert.org.
If you suspect that you have COVID-19, it is essential that you contact your healthcare provider to confirm the diagnosis and to determine if you are at high-risk of requiring hospitalization. These treatments can reduce the severity of COVID-19 in…
The SADS Foundation just released a COVID-19 Vaccine statement that recommends that all individuals with SADS conditions receive a vaccination.
Michael J. Ackerman, MD, PhD, director of the Long QT Syndrome Clinic and professor of medicine,…
Three new drugs have been added and one removed from the Possible Risk of TdP category for the QTdrugs list.
Two drugs used for prostate cancer (Bicalutamide and Relugolix) and an antibiotic (Linezolid) have been added to the Possible Risk category.…
Text for citing the use of the QTdrugs List or the CredibleMeds.org website:
Woosley RL, Heise CW , Gallo T, Tate J, Woosley D and Romero KA, www.CredibleMeds.org, QTdrugs List, [Accession Date], AZCERT, Inc. 1457 E. Desert Garden Dr., Tucson, AZ 85718
Copyright: The CredibleMeds® website is intended for personal and professional use only. Its content is protected by U.S. Copyright. Unauthorized use for commercial purposes is prohibited.
Print
Share
RSS
Donate
